Report cover image

Radiation Dose Management Market by Function (Dose Monitoring, Benchmarking, Reporting, Radiation Management), Technology (AI [ML, Computer Vision), Deployment, Modality (CT, PET, SPECT), Application (Onco), End User (Hospital) - Global Forecast to 2031

Publisher MarketsandMarkets
Published Sep 03, 2026
Length 489 Pages
SKU # MKMK21569407

Description

The radiation dose management market is projected to reach USD 0.96 billion by 2031 from USD 0.51 billion in 2026, at a CAGR of 13.3% from 2026 to 2031. The market is experiencing steady growth owing to the increasing utilization of medical imaging procedures, rising focus on patient radiation safety, regulatory emphasis on radiation dose monitoring and optimization, and growing adoption of automated dose management systems. The increasing volume and complexity of imaging procedures are accelerating the use of RDM systems across hospitals, healthcare systems, diagnostic and imaging centers, and other imaging facilities. These systems enable healthcare organizations to collect, monitor, archive, analyze, and share patient radiation dose data; identify dose variations; compare radiation exposure across facilities and procedures; support diagnostic reference levels (DRLs); and optimize imaging practices.

“By offering, solutions accounted for the dominant share of the radiation dose management market in 2025.”

Based on offering, the radiation dose management market is segmented into solutions and services. The solutions segment accounted for the dominant share of the market in 2025, driven by the increasing adoption of software platforms that automate radiation-dose data collection, monitoring, analysis, reporting, benchmarking, and optimization across medical imaging environments. RDM solutions enable healthcare organizations to collect and analyze dose information from multiple imaging modalities, identify dose variations and outliers, compare radiation exposure against diagnostic reference levels (DRLs), and support imaging-protocol optimization. The solutions segment is also benefiting from the shift from standalone dose-tracking tools toward integrated and interoperable dose-management platforms that connect imaging modalities with PACS, RIS, hospital information systems, and other healthcare IT infrastructure. The continued adoption of automated alerts, dose analytics, patient dose tracking, and advanced optimization capabilities is expected to support demand for RDM solutions throughout the forecast period.

“By deployment model, the cloud-based deployment is expected to witness high growth during the forecast period.”

Based on deployment model, the radiation dose management market is segmented into on-premises and cloud-based/web-based deployment. The cloud-based/web-based deployment segment is expected to register higher CAGR during the forecast period, supported by the increasing need for centralized and remotely accessible dose-management systems across hospitals, diagnostic and imaging centers, and multi-site healthcare networks. Cloud-based and web-based RDM platforms allow healthcare organizations to access dose information across facilities, support centralized monitoring and benchmarking, and reduce the need for extensive on-site infrastructure. The adoption of these deployment models is further supported by the growing need to integrate dose data with PACS, RIS, and other healthcare information systems.

“North America accounted for the largest share of the radiation dose management market in 2025.”

The radiation dose management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the market in 2025, supported by well-established healthcare infrastructure, high adoption of advanced medical imaging technologies, large imaging volumes, and increasing emphasis on radiation safety and dose optimization. The US and Canada have mature healthcare systems with widespread use of CT, fluoroscopy, and interventional imaging, radiography, mammography, and nuclear medicine, creating strong demand for technologies that monitor and manage radiation exposure. Healthcare organizations across the region are increasingly adopting RDM solutions to automate dose monitoring, identify dose variations, benchmark radiation exposure, and support imaging protocol optimization. The presence of established RDM providers and a mature healthcare IT ecosystem further supports adoption of dose management technologies across hospitals, healthcare systems, and diagnostic imaging facilities. The continued expansion of advanced imaging and growing focus on patient safety and efficient dose management are expected to sustain North America's leading position in the RDM market during the forecast period.

The breakdown of primary interview participants is as mentioned below:
  • By Company Type: Tier 1 - 45%, Tier 2 - 35%, and Tier 3 - 20%
  • By Designation: C-level Executives - 26%, Directors - 17%, and Others - 57%
  • By Region: North America - 40%, Europe - 20%, Asia Pacific - 30%, Latin America- 6%, and Middle East – 4%
Bayer AG (Germany) and GE HealthCare (US) are among the key players in the radiation dose management market.
  • The study includes an in-depth competitive analysis of these key players in the radiation dose management market, with their company profiles, recent developments, and key market strategies.
Research Coverage

The report analyzes the radiation dose management market. It aims to estimate the market size and future growth potential of various market segments based on offering, function, technology, deployment model, revenue model, modality, application, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the radiation dose management market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:
  • Analysis of key drivers (increasing utilization and complexity of imaging procedures, increasing regulatory emphasis on dose monitoring, optimization, and reference levels, growing concerns regarding radiation exposure and dose optimization), restraints (high implementation, integration, and maintenance costs, shortage of skilled professionals for radiation dose management and optimization), opportunities (increasing adoption of AI-enabled radiation dose optimization, growing adoption of vendor-neutral and cloud-based dose management platforms, increasing focus on age-specific radiation dose optimization), and challenges (lack of standardized and interoperable dose data across modalities and systems, variability in dose benchmarks and imaging protocols across institutions) influencing the growth of the radiation dose management market
  • Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and new product & service launches in the radiation dose management market
  • Market Development: Comprehensive information about lucrative markets (the report analyzes the radiation dose management market across varied regions)
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the radiation dose management market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Bayer AG (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Sectra AB (Sweden), and FUJIFILM Holdings Corporation (Japan)

Table of Contents

489 Pages
1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Inclusions And Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Stakeholders
1.6 Summary Of Changes
2 Executive Summary
2.1 Key Insights And Market Highlights
2.2 Key Market Participants: Share Insights And Strategic Developments
2.3 Disruptive Trends Shaping Market
2.4 High-growth Segments & Emerging Frontiers
2.5 Snapshot: Global Market Size, Growth Rate, And Forecast
3 Premium Insights
3.1 Radiation Dose Management Market Overview
3.2 North America: Radiation Dose Management Market, By Offering
And Country
3.3 Radiation Dose Management Market: Regional Growth Opportunities
4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Increasing Utilization And Complexity Of Imaging Procedures
4.2.1.2 Increasing Regulatory Emphasis On Dose Monitoring, Optimization, And Reference Levels
4.2.1.3 Growing Concerns Regarding Radiation Exposure And Dose Optimization
4.2.2 Restraints
4.2.2.1 High Implementation And Integration Costs
4.2.2.2 Shortage Of Skilled Professionals For Radiation Dose Management And Optimization
4.2.3 Opportunities
4.2.3.1 Increasing Adoption Of Ai-enabled Radiation Dose Optimization
4.2.3.2 Growing Adoption Of Vendor-neutral And Cloud-based Dose Management Platforms
4.2.3.3 Increasing Focus On Age-specific Radiation Dose Optimization
4.2.4 Challenges
4.2.4.1 Lack Of Standardized And Interoperable Dose Data Across Modalities And Systems
4.2.4.2 Variability In Dose Benchmarks And Imaging Protocols Across Institutions
4.3 Unmet Needs And White Spaces
4.4 Interconnected Markets And Cross-sector Opportunities
4.5 Strategic Moves By Tier-1/2/3 Players
5 Industry Trends
5.1 Porter's Five Forces Analysis
5.1.1 Threat Of New Entrants
5.1.2 Threat Of Substitutes
5.1.3 Bargaining Power Of Suppliers
5.1.4 Bargaining Power Of Buyers
5.1.5 Intensity Of Competitive Rivalry
5.2 Macroeconomic Indicators
5.2.1 Introduction
5.2.2 Gdp Trends And Forecast
5.2.3 Trends In Global Healthcare It Industry
5.3 Value Chain Analysis
5.3.1 Research & Product Development
5.3.2 Data & Knowledge Assets
5.3.3 Software & Platform Infrastructure
5.3.4 Cloud Service Providers
5.3.5 Marketing & Sales
5.3.6 Post-sales Services
5.4 Ecosystem Analysis
5.5 Pricing Analysis
5.5.1 Indicative Price For Radiation Dose Management Market,
By Product (2025)
5.5.2 Indicative Price For Radiation Dose Management Market,
By Region (2025)
5.6 Key Conferences And Events
5.7 Trends/Disruptions Impacting Customers’ Businesses
5.8 Investment And Funding Scenario
5.9 Case Study Analysis
5.9.1 Reducing Ct Dose Through Real-time Dose Monitoring And Alerting
5.9.2 Establishing Enterprise-wide, Multi-modality Dose Management
5.9.3 Reduced Radiation Dose In Specialist Cancer Care
5.9.4 Improved Care Coordination
5.10 Impact Of Us Tariff Overview
5.10.1 Introduction
5.10.2 Key Tariff Rates
5.11 Price Impact Analysis
5.12 Impact On Country/Region
5.12.1 Us
5.12.2 Europe
5.12.3 Asia Pacific
5.13 Impact On End Users
5.13.1 Hospitals And Healthcare Systems
5.13.2 Diagnostic And Imaging Centers
5.13.3 Ambulatory Surgery Centers
5.13.4 Other End Users
6 Strategic Disruption Through Technology, Patents, Digital,
And Ai Adoption
6.1 Key Emerging Technologies
6.1.1 Ai-enabled Radiation Dose Prediction, Monitoring, And Optimization
6.1.2 Patient-specific And Personalized Dosimetry Technologies
6.1.3 Advanced Imaging Technologies For Radiation Dose Optimization
6.2 Complementary Technologies
6.2.1 Dicom, Radiation Dose Structured Reports (Rdsr), And Interoperability Technologies
6.2.2 Cloud-based, Vendor-neutral, And Enterprise Dose Management Architectures
6.2.3 Dose Registries, Benchmarking, And Population-level
Dose Analytics
6.3 Adjacent Technologies
6.3.1 Computational Dosimetry And Patient-specific Dose Modeling
6.4 Technology/Product Roadmap
6.5 Patent Analysis
6.5.1 Patent Publication Trends For Radiation Dose Management
6.5.2 Insights: Jurisdiction And Top Applicant Analysis
6.6 Future Applications
6.6.1 Ai-assisted Personalized Radiation Dose Management
6.6.2 Real-time Dose Optimization And Intelligent Imaging Workflow Automation
6.6.3 Longitudinal Radiation-exposure Management And Predictive Dose Analytics
6.7 Impact Of Ai/Gen Ai On Radiation Dose Management Market
6.7.1 Introduction
6.7.2 Potential Of Ai/Gen Ai In Radiation Dose Management Market
6.7.3 Case Studies Related To Ai/Gen Ai Implementation
6.7.4 Impact Of Ai/Gen Ai On Interconnected And Adjacent Ecosystems
6.7.5 Medical Imaging Equipment & Imaging Informatics
6.7.6 Dose Registries, Benchmarking & Quality Management
6.7.7 Ai-enabled Imaging & Clinical Workflow
6.7.8 User Readiness And Impact Assessment
6.7.8.1 User Readiness
6.7.8.1.1 User A: Hospitals & Integrated Health Systems
6.7.8.1.2 User B: Practices Outpatient Diagnostic Imaging Centers & Radiology Practices
6.7.8.1.3 User C: Interventional Radiology & Cardiology Centers
6.7.8.2 Impact Assessment
6.7.8.2.1 User A: Hospitals & Integrated Health Systems
6.7.8.2.1.1 Implementation
6.7.8.2.1.2 Impact
6.7.8.2.2 User B: Outpatient Diagnostic Imaging Centers & Radiology Practices
6.7.8.2.2.1 Implementation
6.7.8.2.2.2 Impact
6.7.8.2.3 User C: Interventional Radiology & Cardiology Centers
6.7.8.2.3.1 Implementation
6.7.8.2.3.2 Impact
7 Regulatory Landscape
7.1 Regional Regulations And Compliance
7.1.1 Regulatory Bodies, Government Agencies, And Other Organizations
7.1.2 Regulatory Framework
7.1.2.1 North America
7.1.2.2 Europe
7.1.2.3 Asia Pacific
7.1.2.4 Latin America
7.1.2.5 Middle East & Africa
7.1.3 Industry Standards
8 Customer Landscape & Buyer Behavior
8.1 Introduction
8.2 Decision-making Process
8.3 Buyer Stakeholders And Buying Evaluation Criteria
8.4 Key Stakeholders In Buying Process
8.4.1 Key Stakeholders In Buying Process
8.4.2 Buying Criteria
8.5 Adoption Barriers & Internal Challenges
8.6 Unmet Needs From Various End Users
8.6.1 Unmet Needs
8.6.2 End User Expectations
8.7 Market Profitability
9 Radiation Dose Management Market, By Offering
9.1 Introduction
9.2 Solutions
9.2.1 Growing Adoption Of Integrated And Automated Radiation Dose Management Solutions To Drive Market
9.2.2 Standalone Solutions
9.2.2.1 Growing Demand For Flexible And Cost-effective Dose Monitoring Solutions To Boost Market
9.2.3 Integrated Solutions
9.2.3.1 Growing Need For Enterprise-wide, Multi-vendor Dose Management To Propel Market
9.3 Services
9.3.1 Growing Need For Specialized Implementation, Consulting, And Training Expertise To Boost Market
9.3.2 Support & Maintenance Services
9.3.2.1 Growing Need For Continuous System Availability And Software Updates To Boost Market
9.3.3 Implementation & Integration Services
9.3.3.1 Growing Hospital Networks To Drive Demand For Implementation And Integration Services
9.3.4 Consulting Services
9.3.4.1 Growing Need To Interpret Dose Trends And Identify Outliers To Drive Segment
9.3.5 Education & Training Services
9.3.5.1 Increasing Need For Skilled Personnel To Support Radiation Dose Optimization To Boost Segment
10 Radiation Dose Management Market, By Function
10.1 Introduction
10.2 Dose Tracking & Monitoring
10.2.1 Increasing Adoption Of Automated And Continuous Dose Monitoring
10.3 Dose Analytics & Benchmarking
10.3.1 Growing Need To Identify Dose Outliers And Benchmark Imaging Performance Boosts Segment
10.4 Dose Reporting & Regulatory Compliance
10.4.1 Increasing Regulatory Emphasis On Radiation Dose Documentation To Propel Segment
10.5 Protocol & Dose Optimization
10.5.1 Segment Driven By Increasing Focus On Dose Reduction While Maintaining Diagnostic Image Quality
10.6 Patient Radiation Exposure Management
10.6.1 Growing Focus On Patient-specific And Cumulative Radiation Exposure – Key Driver
10.7 Other Functions
10.7.1 Increasing Need For Interoperability Across Heterogeneous Imaging Environments To Drive Segment
11 Radiation Dose Management Market, By Technology
11.1 Introduction
11.2 Ai-enabled Technology
11.2.1 Growing Adoption Of Ai Drives Segment Growth
11.2.2 Machine Learning
11.2.2.1 Growing Adoption Of Predictive And Patient-specific Dose Optimization To Boost Segment
11.2.3 Deep Learning
11.2.3.1 Increasing Use Of Deep Learning For Automated Imaging And Dose Optimization
11.2.4 Computer Vision
11.2.4.1 Increasing Automation Of Image Analysis And Anatomical Assessment To Drive Segment
11.2.5 Natural Language Processing (Nlp)
11.2.5.1 Increasing Availability Of Unstructured Clinical Data – Key Driver
11.3 Non-ai/Conventional Technology
11.3.1 Established Clinical Adoption And Regulatory Reliability
12 Radiation Dose Management Market, By Deployment Model
12.1 Introduction
12.2 On-premise Deployment
12.2.1 Stringent Data-security Policies Drives Segment Growth
12.3 Cloud-based/Web-based Deployment
12.3.1 Increasing Need For Scalable, Multi-site Dose Monitoring And Remote Access To Imaging Analytics Boosts Demand
13 Radiation Dose Management Market, By Revenue Model
13.1 Introduction
13.2 Capital/Annual Purchase Model
13.2.1 Established Procurement Practices Drive Demand
13.3 Pay-per-procedure Model
13.3.1 Affordability Drives Segment Growth
14 Radiation Dose Management Market, By Modality
14.1 Introduction
14.2 Computed Tomography (Ct)
14.2.1 Rapid Adoption Of Photon-counting Ct And Ai-based Reconstruction To Drive Segment
14.3 Fluoroscopy & Interventional Imaging
14.3.1 Rising Procedural Complexity Increases Demand For Real-time Radiation Dose Reduction
14.4 Radiography
14.4.1 Digital Radiography And Ai-based Image Enhancement Enable Lower Exposure
14.5 Mammography
14.5.1 Expansion Of 3d Breast Imaging Drives Demand
14.6 Nuclear Medicine
14.6.1 Increasing Use Of High-sensitivity Pet/Spect And Ai-enabled Reconstruction To Drive Segment
14.6.2 Pet
14.6.2.1 Higher Pet Sensitivity And Ai Reconstruction To Boost Demand
14.6.3 Spect
14.6.3.1 Low-dose Spect/Ct Technologies Strengthen Radiation Optimization
14.6.4 Hybrid
14.6.4.1 Growing Reliance On Pet/Ct And Spect/Ct Drives Market
15 Radiation Dose Management Market, By Application
15.1 Introduction
15.2 Oncology
15.2.1 Increasing Focus On Oncology Drives Demand
15.3 Cardiology
15.3.1 Increasing Use In Cardiology Boosts Demand
15.4 Orthopedic
15.4.1 High Complexity Of Procedures Drives Demand
15.5 Dental
15.5.1 Growing Use Of Cbct Propels Demand
15.6 Other Applications
15.6.1 Need To Manage Repeated Examinations Drives Demand
16 Radiation Dose Management Market, By End User
16.1 Introduction
16.2 Hospitals & Healthcare Systems
16.2.1 Diverse Imaging Fleets Drive Centralized Rdm And Protocol Optimization Across Hospital Networks
16.3 Diagnostic & Imaging Centers
16.3.1 High Examination Volumes And Multi-site Imaging Operations Accelerate Demand
16.4 Ambulatory Care Settings
16.4.1 Expansion Of Outpatient And Ambulatory Imaging Increases Demand
16.5 Academic & Research Institutes
16.5.1 Segment Driven By Ai-driven Low-dose Imaging And Next-generation Dose Optimization Technologies
16.6 Other End Users
16.6.1 Regulatory Oversight, Population-level Radiation Monitoring, And Clinical-trial – Key Drivers
17 Radiation Dose Management Market, By Region
17.1 Introduction
17.2 North America
17.2.1 Macroeconomic Outlook For North America
17.2.2 Us
17.2.2.1 Regulatory Focus On Radiation Safety Drives Market
17.2.3 Canada
17.2.3.1 Increasing Number Of Diagnostic Imaging Procedures To Boost Market
17.3 Europe
17.3.1 Macroeconomic Outlook For Europe
17.3.2 Germany
17.3.2.1 Rising Diagnostic Imaging Demand And Aging Population To Drive Market
17.3.3 France
17.3.3.1 Healthcare Modernization To Accelerate Radiation Dose Management Adoption
17.3.4 Uk
17.3.4.1 Rising Imaging Volumes And Nhs Digitalization To Support Market Growth
17.3.5 Italy
17.3.5.1 Regulatory Emphasis On Dose Optimization And Monitoring To Propel Market
17.3.6 Spain
17.3.6.1 Growing Focus On Patient Dosimetry And Radiation Dose Optimization To Drive Market
17.3.7 Rest Of Europe
17.4 Asia Pacific
17.4.1 Macroeconomic Outlook For Asia Pacific
17.4.2 China
17.4.2.1 Largest Patient Pool And Increased Healthcare Spending To Aid Market Growth
17.4.3 Japan
17.4.3.1 Large And Technologically Advanced Hospital Infrastructure
17.4.4 India
17.4.4.1 Favorable Government Policies And Improved Healthcare Infrastructure To Support Market Growth
17.4.5 Australia
17.4.5.1 Advancement Of National Diagnostic Reference Levels To Accelerate Radiation Dose Optimization
17.4.6 South Korea
17.4.6.1 Increasing Medical Imaging Volumes And Patient Radiation Exposure To Boost Market
17.4.7 Rest Of Asia Pacific
17.5 Latin America
17.5.1 Macroeconomic Outlook For Latin America
17.5.2 Brazil
17.5.2.1 Increasing Regulatory Focus And Adoption Of Advanced Imaging Technologies To Drive Market
17.5.3 Mexico
17.5.3.1 Rising Demand For Diagnostic Imaging And Adoption Of Lower-dose Technologies To Support Market Growth
17.5.4 Rest Of Latin America
17.6 Middle East & Africa
17.6.1 Macroeconomic Outlook For Middle East & Africa
17.6.2 Gcc Countries
17.6.2.1 Saudi Arabia
17.6.2.1.1 Growing Healthcare Expenditure To Boost Market Growth
17.6.2.2 Uae
17.6.2.2.1 Increasing Healthcare Infrastructure Investments To Drive Market Growth
17.6.2.3 Rest Of Gcc
17.6.3 South Africa
17.6.3.1 Increasing Focus On Radiation Dose Optimization To Propel Market Growth
17.6.4 Rest Of Middle East & Africa
18 Competitive Landscape
18.1 Overview
18.2 Key Player Strategies/Right To Win, 2023–2026
18.3 Revenue Analysis, 2021-2025
18.4 Market Share Analysis, 2021–2025
18.5 Brand Comparison
18.6 Company Valuation And Financial Metrics
18.7 Company Evaluation Matrix: Key Players, 2025
18.7.1 Stars
18.7.2 Emerging Leaders
18.7.3 Pervasive Players
18.7.4 Participants
18.7.5 Company Footprint: Key Players, 2025
18.7.5.1 Company Footprint
18.7.5.2 Region Footprint
18.7.5.3 Offering Footprint
18.7.5.4 Deployment Model Footprint
18.7.5.5 Technology Footprint
18.8 Company Evaluation Matrix: Startups/Smes, 2025
18.8.1 Progressive Companies
18.8.2 Responsive Companies
18.8.3 Dynamic Companies
18.8.4 Starting Blocks
18.8.5 Competitive Benchmarking Startups/Smes, 2025
18.9 Competitive Scenario
18.9.1 Deals
18.9.2 Other Developments
19 Company Profiles
19.1 Key Players
19.1.1 Bayer Ag
19.1.1.1 Products/Solutions/Services Offered
19.1.1.2 Recent Developments
19.1.1.2.1 Product Launches & Upgrades
19.1.1.2.2 Deals
19.1.1.2.3 Other Developments
19.1.1.3 Mnm View
19.1.1.3.1 Key Strengths
19.1.1.3.2 Strategic Choices
19.1.1.3.3 Weaknesses And Competitive Threats
19.1.2 Siemens Healthineers Ag
19.1.2.1 Business Overview
19.1.2.2 Products/Solutions/Services Offered
19.1.2.3 Recent Developments
19.1.2.3.1 Product Launches & Upgrades
19.1.2.3.2 Deals
19.1.2.3.3 Expansions
19.1.2.4 Mnm View
19.1.2.4.1 Key Strengths
19.1.2.4.2 Strategic Choices
19.1.2.4.3 Weaknesses And Competitive Threats
19.1.3 Koninklijke Philips N.V.
19.1.3.1 Business Overview
19.1.3.2 Products/Solutions/Services Offered
19.1.3.3 Recent Developments
19.1.3.3.1 Product Launches & Upgrades
19.1.3.3.2 Deals
19.1.3.4 Mnm View
19.1.3.4.1 Key Strengths
19.1.3.4.2 Strategic Choices
19.1.3.4.3 Weaknesses And Competitive Threats
19.1.4 Ge Healthcare
19.1.4.1 Business Overview
19.1.4.2 Products/Solutions/Services Offered
19.1.4.3 Recent Developments
19.1.4.3.1 Product Launches & Upgrades
19.1.4.3.2 Deals
19.1.4.3.3 Other Developments
19.1.4.4 Mnm View
19.1.4.4.1 Key Strengths
19.1.4.4.2 Strategic Choices
19.1.4.4.3 Weaknesses And Competitive Threats
19.1.5 Fujifilm Holdings Corporation
19.1.5.1 Business Overview
19.1.5.2 Products/Solutions/Services Offered
19.1.5.3 Recent Developments
19.1.5.3.1 Product Launches & Upgrades
19.1.5.3.2 Deals
19.1.5.3.3 Other Developments
19.1.5.4 Mnm View
19.1.5.4.1 Key Strengths
19.1.5.4.2 Strategic Choices
19.1.5.4.3 Weaknesses And Competitive Threats
19.1.6 Sectra Ab
19.1.6.1 Business Overview
19.1.6.2 Products/Solutions/Services Offered
19.1.6.3 Recent Developments
19.1.6.3.1 Product Launches & Upgrades
19.1.6.3.2 Deals
19.1.6.3.3 Other Developments
19.1.7 Canon Inc.
19.1.7.1 Business Overview
19.1.7.2 Products/Solutions/Services Offered
19.1.7.3 Recent Developments
19.1.7.3.1 Product Launches & Upgrades
19.1.7.3.2 Deals
19.1.7.3.3 Other Developments
19.1.8 Agfa-gevaert N.V.
19.1.8.1 Business Overview
19.1.8.2 Products/Solutions/Services Offered
19.1.8.3 Recent Developments
19.1.8.3.1 Product Launches & Upgrades
19.1.8.3.2 Deals
19.1.9 Pacshealth, Llc
19.1.9.1 Business Overview
19.1.9.2 Products/Solutions/Services Offered
19.1.9.3 Recent Developments
19.1.9.3.1 Deals
19.1.10 Qaelum
19.1.10.1 Business Overview
19.1.10.2 Products/Solutions/Services Offered
19.1.10.3 Recent Developments
19.1.10.3.1 Deals
19.1.11 Medsquare
19.1.11.1 Business Overview
19.1.11.2 Products/Solutions/Services Offered
19.1.11.3 Recent Developments
19.1.11.3.1 Product Launches & Upgrades
19.1.11.3.2 Deals
19.1.12 Novarad
19.1.12.1 Business Overview
19.1.12.2 Products/Solutions/Services Offered
19.1.13 Infinitt Healthcare Co., Ltd.
19.1.13.1 Business Overview
19.1.13.2 Products/Solutions/Services Offered
19.1.14 Carestream Health
19.1.14.1 Business Overview
19.1.14.2 Products/Solutions/Services Offered
19.1.14.3 Recent Developments
19.1.14.3.1 Product Launches & Upgrades
19.1.14.3.2 Deals
19.1.15 Shimadzu Corporation
19.1.15.1 Business Overview
19.1.15.2 Products/Solutions/Services Offered
19.1.15.3 Recent Developments
19.1.15.3.1 Products Launches & Upgrades
19.1.15.3.2 Deals
19.1.16 Nanjing Perlove Medical Equipment Co., Ltd.
19.1.16.1 Business Overview
19.1.16.2 Products/Solutions/Services Offered
19.1.16.3 Recent Developments
19.1.16.3.1 Product Launches & Upgrades
19.1.16.3.2 Deals
19.1.17 Neusoft Medical Systems Co., Ltd.
19.1.17.1 Business Overview
19.1.17.2 Products/Solutions/Services Offered
19.1.17.3 Recent Developments
19.1.17.3.1 Product Launches & Upgrades
19.1.17.3.2 Deals
19.1.18 Konica Minolta, Inc
19.1.18.1 Business Overview
19.1.18.2 Products/Solutions/Services Offered
19.1.18.3 Recent Developments
19.1.18.3.1 Product Launches & Upgrades
19.1.18.3.2 Deals
19.1.19 Iba
19.1.19.1 Business Overview
19.1.19.2 Products/Solutions/Services Offered
19.1.19.3 Recent Developments
19.1.19.3.1 Product Launches & Upgrades
19.1.19.3.2 Deals
19.1.20 Lunit Inc.
19.1.20.1 Business Overview
19.1.20.2 Products/Solutions/Services Offered
19.1.20.3 Recent Developments
19.1.20.3.1 Deals
19.2 Other Players
19.2.1 Qit Systeme Gmbh
19.2.2 Imalogix
19.2.3 Idose
19.2.4 Myxraydose Ltd.
19.2.5 Virtual Phantoms Inc.
20 Research Methodology
20.1 Research Approach
20.1.1 Secondary Research
20.1.1.1 Key Data From Secondary Sources
20.1.2 Primary Research
20.1.2.1 Key Data From Primary Sources
20.1.2.2 Insights From Primary Experts
20.2 Research Methodology
20.3 Market Size Estimation
20.4 Market Breakdown Data Triangulation
20.5 Market Share Estimation
20.6 Study Assumptions
20.7 Limitations
20.7.1 Scope-related Limitations
20.7.2 Methodology-related Limitations
20.8 Risk Assessment
21 Appendix
21.1 Discussion Guide
21.2 Knowledgestore: Marketsandmarkets’ Subscription Portal
21.3 Customization Options
21.4 Related Reports
21.5 Author Details

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.